Effect of hyperbaric oxygen therapy in experimental subcutaneous and pulmonary infections due to Pseudomonas aeruginosa.

Luongo, C; Imperatore, F; Matera, M G; Mangoni, G; Marmo, M; Baroni, A; Catalanotti, P; Rossi, F; Filippelli, A

Luongo, C; Imperatore, F; Matera, M G; Mangoni, G; Marmo, M; Baroni, A; Catalanotti, P; Rossi, F; Filippelli, A.

Affiliation

Luongo C; Institute of Pharmacology and Toxicology, 2nd University of Naples, Italy.

Undersea Hyperb Med ; 26(1): 21-5, 1999.

Article in En | MEDLINE | ID: mdl-10353181

Subject(s)

Hyperbaric Oxygenation; Lung Diseases/therapy; Pseudomonas Infections/therapy; Skin Diseases, Bacterial/therapy; Amikacin/therapeutic use; Animals; Anti-Bacterial Agents/therapeutic use; Combined Modality Therapy; Lung Diseases/drug therapy; Lung Diseases/microbiology; Male; Pseudomonas Infections/drug therapy; Pseudomonas Infections/microbiology; Pseudomonas aeruginosa; Rats; Rats, Wistar; Skin Diseases, Bacterial/drug therapy; Skin Diseases, Bacterial/microbiology

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Pseudomonas Infections / Skin Diseases, Bacterial / Hyperbaric Oxygenation / Lung Diseases Limits: Animals Language: En Journal: Undersea Hyperb Med Year: 1999 Document type: Article

Search on Google

XML

PubMed Links